Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug developmentAMSTERDAM & BOSTON--(BUSINESS WIRE)--VectoryY Therapeutics, a leader ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

UAE: Her Excellency Dr. Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment, launched the first edition of the Sustainability Impact Forum during the World Governments Summit 2026.

Key cyber updates on ransomware, cloud intrusions, phishing, botnets, supply-chain risks, and nation-state threat activity.

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.